Abacavir Base (CAS number 188062-50-2) is a significant drug primarily utilized in the therapy of HIV disease and connected additional illnesses . It functions as a nucleoside-like suppressor, interfering with the viral reproduction process . Administered often in alongside other AIDS drugs , abacavir has a vital role in reducing the HIV quantity and improving individual well-being . Careful HLA testing for the B*57:01 allele is essential prior to commencement of abacavir's therapy to reduce the risk of a severe reaction .
Abarelix (183552-38-7): Properties and Uses
Abarelix, identified by the Chemical ID 183552-38-7, is a synthetic protein antagonist of gonadotropin-releasing hormone (GnRH). Its primary characteristic lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a profound decrease in gonadotropin production . Medically , abarelix is applied primarily in the treatment of advanced prostate disease; however, research also explores potential roles in other hormonal disorders and reproductive health . The compound 's composition allows for selective receptor connection.
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The synthetic of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves complex multistep laboratory routes. Several published methods exist, often beginning with Androstadienedione and utilizing specific oxidation and esterification steps. A typical procedure includes protecting group strategies to ensure desired regioselectivity. Analytical results, crucial for quality control, routinely employs liquid chromatography (HPLC) for measurement of impurities. Nuclear Magnetic Resonance (NMR) spectroscopy confirms the molecular identity. Mass spectrometry provides molecular weight validation. Other analyses, like infrared (IR) analysis, assist in identification and are important for batch release.
- Synthesis Routes
- Purity Control
- Spectroscopic Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Knowing these identifiers aids in accurate referencing and prevents ambiguity within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Properly utilizing these numbers ensures clarity and reliability when discussing these medications.
- The Antiretroviral CAS Number: 60242-78-0
- Abarelix CAS Number: 5490-02-9
- Compound C CAS Number: 857342-50-7
```
Important Details on Abacavir Sulfate , Abarelix Injection , and Abiraterone
These medications represent distinct approaches in AMINOQUINOLINE 578-66-5 medicine. Abacavir Sulfate is a medicine primarily given to combat HIV infection , often in combination other antiviral . Abarelix Injection is a medication that acts as a GnRH antagonist , typically employed to reduce prostate growths before operation . Lastly, Abiraterone Drug is another treatment given to treat advanced prostate cancer , specifically suppressing testosterone creation. Always speak with a physician for detailed information and advice regarding any prescription .
Drug Perspectives: Abacavir Salt, Abarelix, Abiraterone Drug and Their Chemical Abstracts Service Numbers
Understanding key therapeutic compounds requires the defined recognition. Notably, Abacavir Sulfate, utilized in retroviral treatment, is a Registration Number of 3870-92-6. In the same way, Abarelix, the hormone blocker employed during prostate growths management, bears the CAS Identifier 64347-82-2. Finally, Abiraterone Acetate, a compound in metastatic testicular cancer, can be associated with the Chemical Abstracts Service Number 864930-63-3. Such codes represent vital tools for accurate pharmaceutical referencing and study.